Atlas Trials

Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy

Clinical trial NCT06706544 · RECRUITING

Trial details

NCT number
NCT06706544
Sponsor
Bernardino Clavo, MD, PhD
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Chemotherapy Induced Peripheral Neuropathy (CIPN)ParesthesiaNumbnessTingling
Start date
2025-02-07
Primary completion
2029-12-31
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.